Monopar Therapeutics Inc.

NASDAQ:MNPR

Biotechnology

Healthcare
$70.75 +2.45%

+$1.58 today

Market cap
$479.46M
Beta
1.54
P/E (TTM)
-37.6
EPS (TTM)
-$1.76
52W Low $29.18High $105.00

Volume 0.10M

Average 0.17M

Balance Sheet

Inspect the capital base behind the business.

Assets

$140.72M

FY 2025 · Annual

+133.4% YoY

Liabilities

$2.89M

FY 2025 · Annual

-45.0% YoY

Equity

$137.83M

FY 2025 · Annual

+150.4% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents20.3M8.19M7.27M45.82M61.83M
Short-term Investments04.93M014.4M78.57M
Net Receivables00000
Inventory00000
Other Current Assets217.75K45.98K66.43K78.87K63.75K
Total Current Assets20.52M13.17M7.33M60.29M140.46M
Property, Plant & Equipment (Net)061.23K12.65K0254.92K
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets00000
Total Non-current Assets061.23K12.65K0254.92K
Total Assets20.52M13.23M7.35M60.29M140.72M
Account Payables1.58M3.13M1.76M2.25M2.74M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities00000
Total Current Liabilities1.58M3.13M1.76M5.25M2.74M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities08.41K00154.92K
Total Liabilities1.58M3.14M1.76M5.25M2.89M
Common Stock12.6K12.95K14.91K6.1K6.69K
Retained Earnings(41.29M)(51.8M)(60.21M)(75.79M)(89.51M)
Accumulated OCI(3.16K)8.94K(14.13K)35.99K131.39K
Other Stockholders Equity00000
Minority Interest00000
Total Equity18.94M10.09M5.59M55.04M137.83M
Total Debt08.41K00154.92K
Net Debt(20.3M)(8.18M)(7.27M)(45.82M)(61.68M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$52.5M
Short-term Investments$84.9M
Other Current$250.9K
Total Current Assets$137.7M
PP&E (Net)$239.9K
Total Non-current Assets$239.9K
Total Assets$138.0M

Analysis

Selected assets total $138.0M for Latest. The largest visible component is Short-term Investments at $84.9M, about 61.6% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 12, 2026
10-QQuarterly reportNov 12, 2026
4Statement of changes in beneficial ownershipNov 4, 2026
4Statement of changes in beneficial ownershipNov 4, 2026
SC 13GSC 13G filingOct 27, 2026

How much cash does MNPR have?

Monopar Therapeutics Inc. (MNPR) reported $61.83M in cash and equivalents in fiscal 2025.

How much debt does MNPR carry?

Monopar Therapeutics Inc. (MNPR) reported $154,920.00 of total debt, with net debt of -$61.68M.